The document provides an overview of changes made in revising ISO/IEC 17025. Key changes include:
- Adding definitions for intralaboratory comparison and proficiency testing.
- Clarifying the definition of laboratory to include calibration, testing, and sampling associated with subsequent calibration or testing.
- Requiring laboratories to identify risks to impartiality and address them.
- Emphasizing customer awareness of policies regarding confidentiality.
- Focusing on ensuring laboratories have access to necessary resources rather than owning them.
- Providing two options (A or B) for management system requirements, aligned with ISO 9001:2015 or addressing specific clauses.
The document summarizes revisions made to ISO/IEC 17025:2017, the standard for testing and calibration laboratories. Key changes include:
- Aligning the structure and language with other ISO standards and emphasizing outcomes over prescriptive requirements.
- Adding definitions for terms like "intralaboratory comparison" and updating terms like "impartiality".
- Focusing on risk-based thinking and giving laboratories more flexibility in meeting requirements.
- Emphasizing process approaches and addressing new areas like information technology and electronic documents.
- Providing two options for management system requirements - addressing specific clauses or using ISO 9001:2015.
This document provides a detailed comparison of the changes between ISO 13485:2003 and ISO 13485:2016 for quality management systems in the medical device industry. It outlines numerous additions and clarifications to requirements for areas such as documentation, risk management, design and development, purchasing, production, complaints handling, nonconforming products, and data analysis. Organizations must transition to the new 2016 standard and undergo an audit to ensure compliance with the new requirements before March 2019.
From May 2017, NQA is able to carry out transition audits to the revised medical device standard as a part of your next assessment.
Every organization which wishes to maintain certification to this standard must undergo a transition audit before March 2019 including resolution of any/all non-conformances raised during
the transition audit. To help get you started, the helpful annexes in the new standard have been expanded to give you more detail on where to focus your attention to understand and implement the
required changes. The work required will of course depend on your products/services and the nonapplicable cause specific to your QMS.
This document discusses change control in the pharmaceutical industry. It begins by defining change control as a formal system to review proposed or actual changes that could affect facilities, systems, equipment, or processes. The functions of change control are then outlined as identifying, reviewing, approving, validating, analyzing, and monitoring changes. The areas of change that would require control are described, including manufacturing, quality control, research and development, engineering, and marketing. Finally, the document states that written procedures and documentation like standard operating procedures and change control forms are necessary parts of the change control system.
PECB Webinar: ISO 29001:2010 – Supplemental Requirements & Impact of ISO 9001...PECB
If you have wondered what are the similarities and differences of ISO 29001 and ISO 9001, this is your chance to learn it. You will also see the requirements and what impact does Quality Management System has in Oil and Gas industry, especially the requirements of ISO 29001.
You will learn all this in two sessions, which will be presented by PECB trainer David Smart, Managing Director of Smart ISO Systems / Smart Mentoring. David’s personal experience spans more than 40 years as a Manager, Auditor and Consultant, specializing in multiple fields related to ISO standards. He is a Lead auditor for ISO 27001, ISO 13485, ISO 9001, ISO 14001, ISO 29001, ISO 17025 and OHSAS 18001, and an active member of various institutes.
This document discusses validation of analytical methods. It defines validation as establishing evidence that a process will consistently produce results meeting specifications. Validation guidelines include ICH Q2A, Q2B, FDA guidance, and pharmacopoeias. Key validation characteristics covered are specificity, linearity, range, accuracy, precision, detection/quantitation limits, robustness, and system suitability testing. Equipment validation involves design qualification, installation qualification, operational qualification, performance qualification, and process qualification in three phases: pre-validation, process validation, and validation maintenance.
ISO 17025 Accreditation Detail Review Abdul Rahman
In this presentation, you would get knowledge about ISO17025. It's an updated version, terms and definitions. Which documents are required for certification.
Validation is the process of documenting that a specific process, method, or system consistently produces results meeting predetermined specifications and quality attributes. It is important for ensuring regulatory compliance and product quality. Validation involves qualification of equipment, facilities, analytical methods, and processes.
For equipment validation, there are key phases - design qualification, installation qualification, operational qualification, and performance qualification - to demonstrate the equipment is suitable for its intended purposes. Process validation also involves defining critical process parameters, in-process testing, and method validation to control quality. Proper validation helps reduce issues and ensure consistent manufacturing of products meeting quality standards.
The document summarizes revisions made to ISO/IEC 17025:2017, the standard for testing and calibration laboratories. Key changes include:
- Aligning the structure and language with other ISO standards and emphasizing outcomes over prescriptive requirements.
- Adding definitions for terms like "intralaboratory comparison" and updating terms like "impartiality".
- Focusing on risk-based thinking and giving laboratories more flexibility in meeting requirements.
- Emphasizing process approaches and addressing new areas like information technology and electronic documents.
- Providing two options for management system requirements - addressing specific clauses or using ISO 9001:2015.
This document provides a detailed comparison of the changes between ISO 13485:2003 and ISO 13485:2016 for quality management systems in the medical device industry. It outlines numerous additions and clarifications to requirements for areas such as documentation, risk management, design and development, purchasing, production, complaints handling, nonconforming products, and data analysis. Organizations must transition to the new 2016 standard and undergo an audit to ensure compliance with the new requirements before March 2019.
From May 2017, NQA is able to carry out transition audits to the revised medical device standard as a part of your next assessment.
Every organization which wishes to maintain certification to this standard must undergo a transition audit before March 2019 including resolution of any/all non-conformances raised during
the transition audit. To help get you started, the helpful annexes in the new standard have been expanded to give you more detail on where to focus your attention to understand and implement the
required changes. The work required will of course depend on your products/services and the nonapplicable cause specific to your QMS.
This document discusses change control in the pharmaceutical industry. It begins by defining change control as a formal system to review proposed or actual changes that could affect facilities, systems, equipment, or processes. The functions of change control are then outlined as identifying, reviewing, approving, validating, analyzing, and monitoring changes. The areas of change that would require control are described, including manufacturing, quality control, research and development, engineering, and marketing. Finally, the document states that written procedures and documentation like standard operating procedures and change control forms are necessary parts of the change control system.
PECB Webinar: ISO 29001:2010 – Supplemental Requirements & Impact of ISO 9001...PECB
If you have wondered what are the similarities and differences of ISO 29001 and ISO 9001, this is your chance to learn it. You will also see the requirements and what impact does Quality Management System has in Oil and Gas industry, especially the requirements of ISO 29001.
You will learn all this in two sessions, which will be presented by PECB trainer David Smart, Managing Director of Smart ISO Systems / Smart Mentoring. David’s personal experience spans more than 40 years as a Manager, Auditor and Consultant, specializing in multiple fields related to ISO standards. He is a Lead auditor for ISO 27001, ISO 13485, ISO 9001, ISO 14001, ISO 29001, ISO 17025 and OHSAS 18001, and an active member of various institutes.
This document discusses validation of analytical methods. It defines validation as establishing evidence that a process will consistently produce results meeting specifications. Validation guidelines include ICH Q2A, Q2B, FDA guidance, and pharmacopoeias. Key validation characteristics covered are specificity, linearity, range, accuracy, precision, detection/quantitation limits, robustness, and system suitability testing. Equipment validation involves design qualification, installation qualification, operational qualification, performance qualification, and process qualification in three phases: pre-validation, process validation, and validation maintenance.
ISO 17025 Accreditation Detail Review Abdul Rahman
In this presentation, you would get knowledge about ISO17025. It's an updated version, terms and definitions. Which documents are required for certification.
Validation is the process of documenting that a specific process, method, or system consistently produces results meeting predetermined specifications and quality attributes. It is important for ensuring regulatory compliance and product quality. Validation involves qualification of equipment, facilities, analytical methods, and processes.
For equipment validation, there are key phases - design qualification, installation qualification, operational qualification, and performance qualification - to demonstrate the equipment is suitable for its intended purposes. Process validation also involves defining critical process parameters, in-process testing, and method validation to control quality. Proper validation helps reduce issues and ensure consistent manufacturing of products meeting quality standards.
Validation is the process of establishing documented evidence that a process or system does what it is intended to do. There are three main types of validation: process validation, cleaning validation, and equipment validation. Process validation involves collecting data throughout production to prove a process can consistently deliver quality products. It can be done prospectively, concurrently, or retrospectively. Cleaning validation ensures that cleaning processes minimize cross-contamination. Equipment validation proves equipment works correctly. Validation protocols specify the validation activities and acceptance criteria. The key phases of validation are prevalidation qualification, process validation, and validation maintenance.
This document discusses validation in the pharmaceutical industry. It begins by defining validation as documented evidence that a process will consistently produce products meeting specifications. It then discusses the scope of validation, including selection of raw materials, product and process design, quality control parameters, and validation of related systems. Stakeholders in validation like R&D, engineering, and quality assurance are identified. Types of validation like analytical method validation, process validation, cleaning validation, and equipment validation are also summarized.
This document discusses changes and requirements regarding personnel competence in ISO/IEC 17025:2017. It notes that the standard now requires laboratories to monitor personnel competence after authorization. It provides examples of documenting competence for various job functions and evaluating evidence of personnel qualifications. The document emphasizes that laboratories must define competence criteria for all roles influencing results and have procedures and records for determining, evaluating, authorizing, supervising, and monitoring personnel competence.
Specific Detailed Changes to the New ISO 13485:2016Greenlight Guru
Today's medical device regulatory environment is changing faster than ever. Keeping up can be daunting. The new quality management standard ISO 13485:2016 was published in Q1 of 2016.
greenlight.guru has partnered with special guest and consultant, Mark Swanson, to keep you ahead of these changes.
Mark spent the last 4 years on the working group that revised the new ISO 13485.
Mark has all the exclusive insider knowledge on the changes you want. And he's going to be sharing it with you for free.
(You can view the full webinar here: http://www.greenlight.guru/webinar/iso-13485-2016-changes)
In this webinar you'll learn specifically:
-How to prepare for the coming regulatory changes with ISO 13485:2016
-How to apply risk based thinking to your quality processes to ensure compliance
-What you need to know about the design control updates
-How to incorporate ISO 9001:2015 and 13485:2016 to your supplier controls
-A general overview of the standard and its most significant changes (before anyone else)
ISO 15189 2022 standards for laboratory quality and competencePathKind Labs
The fourth edition of standards for laboratory quality and competence are available. Labs need to perform gap analysis to identify areas that need to be developed to fulfill the new requirements.
Walthers & Associates provides requalification services to confirm equipment is still validated and performing as intended. Requalification includes repeating validation tests or assessments and is required annually, when equipment is modified, or for product protection. Tests evaluate microbial reduction through biological indicators, achievement of required temperatures and pressures, and confirmation of cleanliness. Any failures require corrective actions, further "as found" data collection, and may necessitate change control processes. Requalification aims to demonstrate through objective evidence that equipment continuously meets validation requirements.
This document provides guidelines on validation and qualification for pharmaceutical manufacturing. It discusses the importance of validation in ensuring quality products. Key aspects covered include the relationship between validation and qualification, approaches to validation, scope of validation, and calibration. Appendices provide more specific guidance on validation of areas like cleaning, computer systems, equipment, and analytical methods. The overall goal is to help manufacturers design validated processes to consistently produce safe, effective pharmaceuticals.
This document provides information on change control procedures for pharmaceutical companies. It defines what constitutes a change, outlines the scope of change control, and describes the change control process. This includes classifying changes as major or minor, evaluating impacts, obtaining approvals, implementing changes, and closing out change controls. Parameters for assessing impact and risk are also listed. The goal is to formally evaluate, document, approve and implement any changes that could affect quality in a validated manner.
Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
This document provides guidance on process validation for medical device manufacturers. It discusses the purpose and scope of process validation, definitions of key terms, and when processes should be validated versus verified. It describes the three phases of validation: installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). Guidelines are provided for developing validation protocols, conducting validations, and maintaining validated states. Statistical tools that can be used in validation are also summarized. The overall intent is to help manufacturers understand quality system requirements and apply principles of process validation.
The document discusses various aspects of validation including calibration, process validation, analytical method validation, and cleaning validation. It defines validation as a systematic approach to collecting and analyzing data to give reasonable assurance that a process will consistently produce results within predetermined specifications. It describes the scope, organization, and types of validation including process, analytical method, cleaning, and computer system validation. It also discusses key aspects of analytical method validation like accuracy, precision, specificity, linearity, repeatability, intermediate precision, and robustness.
Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...ShopnilAkash5
Validation is the process of establishing documentary evidence demonstrating that a procedure, process, or activity carried out in testing and then production maintains the desired level of compliance at all stages
It is essential to ensure the quality Of a product and Good Manufacturing Practices including all other regulatory requirements
Key factors and main change over in iso 17025 2017Dr.Lenin raja
1. The document discusses changes to ISO 17025:2017 regarding general requirements for testing and calibration laboratories. It outlines key changes to requirements regarding impartiality, confidentiality, organizational structure, personnel competence, equipment, metrological traceability, externally provided products/services, and method selection/validation.
2. New standards specify that laboratories must be committed to impartiality and minimize risks to impartiality. Personnel must keep information confidential, unless legally required. Laboratories must define their organizational structure and personnel responsibilities.
3. Equipment must be suitable for intended measurements and calibrated when it impacts validity or traceability of results. Laboratories must establish traceability of measurements to SI units through an unbroken chain of calibrations.
Process validation establishes documented evidence that a manufacturing process will consistently produce products meeting specifications. It involves qualifying facilities and equipment, validating critical process parameters, and revalidating when changes occur. Validation includes prospective validation of new processes and retrospective validation of existing stable processes by statistical analysis of historical batch data. Documentation of the validation master plan, protocols, reports, and results provide assurance that processes are properly controlled.
This document discusses quality assurance and quality control procedures for chemical test laboratories to meet ISO/IEC 17025:2017 requirements. It covers establishing quality assurance plans, differentiating quality assurance and quality control, applying quality control practices like blanks, replicates, and laboratory controls. Quality control charts are presented as a tool to monitor analytical accuracy and precision over time.
The document summarizes the key changes and structure of ISO/IEC 17025:2017 compared to the 2005 version. Major changes include an expanded scope to include sampling and a process-based approach. It adopts a new high level structure with common clauses across standards. Key requirements include impartiality, confidentiality, personnel competence, facilities, equipment calibration, metrological traceability, and management of externally provided products and services. The standard aims to ensure laboratories consistently operate at a high level of technical competence and quality.
1) Maintaining quality in an analytical laboratory requires fully integrating quality pursuit into all activities and having staff practice quality at all times.
2) A quality system includes procedures and responsibilities to ensure staff have resources to satisfy clients. It involves quality management, assurance, and control.
3) Key aspects of a quality system include a quality manual, audits to ensure compliance, and management reviews to ensure the system meets needs.
PECB Webinar: Overview of ISO 13485 - Medical DevicesPECB
The webinar covers:
• The key section of ISO 13485
• The benefits of ISO 13485
• In brief how ISO 13485 & ISO 9001 correlate
Presenter:
This webinar was presented by Raza Shah, Chief Editor and Owner of Bitehqeeq.
Link of the recorded session published on YouTube: https://youtu.be/gZlhUlqgo1g
ISPE-CCPIE China Conference 2010 (Stokes-GAMP Legacy Systems - English)David Stokes
This document summarizes two presentations given at the ISPE-CCPIE China Conference 2010 on validating legacy systems. The first presentation discusses validating a global ERP system for a medical device company and a legacy ERP system for a Chinese pharmaceutical company. It provides guidance on assessing legacy systems, conducting a gap analysis, and developing a risk-based validation approach. The second presentation describes a retrospective validation of a global ERP system and a validation conducted for a change in use of a legacy ERP system in China.
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfSelcen Ozturkcan
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
Validation is the process of establishing documented evidence that a process or system does what it is intended to do. There are three main types of validation: process validation, cleaning validation, and equipment validation. Process validation involves collecting data throughout production to prove a process can consistently deliver quality products. It can be done prospectively, concurrently, or retrospectively. Cleaning validation ensures that cleaning processes minimize cross-contamination. Equipment validation proves equipment works correctly. Validation protocols specify the validation activities and acceptance criteria. The key phases of validation are prevalidation qualification, process validation, and validation maintenance.
This document discusses validation in the pharmaceutical industry. It begins by defining validation as documented evidence that a process will consistently produce products meeting specifications. It then discusses the scope of validation, including selection of raw materials, product and process design, quality control parameters, and validation of related systems. Stakeholders in validation like R&D, engineering, and quality assurance are identified. Types of validation like analytical method validation, process validation, cleaning validation, and equipment validation are also summarized.
This document discusses changes and requirements regarding personnel competence in ISO/IEC 17025:2017. It notes that the standard now requires laboratories to monitor personnel competence after authorization. It provides examples of documenting competence for various job functions and evaluating evidence of personnel qualifications. The document emphasizes that laboratories must define competence criteria for all roles influencing results and have procedures and records for determining, evaluating, authorizing, supervising, and monitoring personnel competence.
Specific Detailed Changes to the New ISO 13485:2016Greenlight Guru
Today's medical device regulatory environment is changing faster than ever. Keeping up can be daunting. The new quality management standard ISO 13485:2016 was published in Q1 of 2016.
greenlight.guru has partnered with special guest and consultant, Mark Swanson, to keep you ahead of these changes.
Mark spent the last 4 years on the working group that revised the new ISO 13485.
Mark has all the exclusive insider knowledge on the changes you want. And he's going to be sharing it with you for free.
(You can view the full webinar here: http://www.greenlight.guru/webinar/iso-13485-2016-changes)
In this webinar you'll learn specifically:
-How to prepare for the coming regulatory changes with ISO 13485:2016
-How to apply risk based thinking to your quality processes to ensure compliance
-What you need to know about the design control updates
-How to incorporate ISO 9001:2015 and 13485:2016 to your supplier controls
-A general overview of the standard and its most significant changes (before anyone else)
ISO 15189 2022 standards for laboratory quality and competencePathKind Labs
The fourth edition of standards for laboratory quality and competence are available. Labs need to perform gap analysis to identify areas that need to be developed to fulfill the new requirements.
Walthers & Associates provides requalification services to confirm equipment is still validated and performing as intended. Requalification includes repeating validation tests or assessments and is required annually, when equipment is modified, or for product protection. Tests evaluate microbial reduction through biological indicators, achievement of required temperatures and pressures, and confirmation of cleanliness. Any failures require corrective actions, further "as found" data collection, and may necessitate change control processes. Requalification aims to demonstrate through objective evidence that equipment continuously meets validation requirements.
This document provides guidelines on validation and qualification for pharmaceutical manufacturing. It discusses the importance of validation in ensuring quality products. Key aspects covered include the relationship between validation and qualification, approaches to validation, scope of validation, and calibration. Appendices provide more specific guidance on validation of areas like cleaning, computer systems, equipment, and analytical methods. The overall goal is to help manufacturers design validated processes to consistently produce safe, effective pharmaceuticals.
This document provides information on change control procedures for pharmaceutical companies. It defines what constitutes a change, outlines the scope of change control, and describes the change control process. This includes classifying changes as major or minor, evaluating impacts, obtaining approvals, implementing changes, and closing out change controls. Parameters for assessing impact and risk are also listed. The goal is to formally evaluate, document, approve and implement any changes that could affect quality in a validated manner.
Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
This document provides guidance on process validation for medical device manufacturers. It discusses the purpose and scope of process validation, definitions of key terms, and when processes should be validated versus verified. It describes the three phases of validation: installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). Guidelines are provided for developing validation protocols, conducting validations, and maintaining validated states. Statistical tools that can be used in validation are also summarized. The overall intent is to help manufacturers understand quality system requirements and apply principles of process validation.
The document discusses various aspects of validation including calibration, process validation, analytical method validation, and cleaning validation. It defines validation as a systematic approach to collecting and analyzing data to give reasonable assurance that a process will consistently produce results within predetermined specifications. It describes the scope, organization, and types of validation including process, analytical method, cleaning, and computer system validation. It also discusses key aspects of analytical method validation like accuracy, precision, specificity, linearity, repeatability, intermediate precision, and robustness.
Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...ShopnilAkash5
Validation is the process of establishing documentary evidence demonstrating that a procedure, process, or activity carried out in testing and then production maintains the desired level of compliance at all stages
It is essential to ensure the quality Of a product and Good Manufacturing Practices including all other regulatory requirements
Key factors and main change over in iso 17025 2017Dr.Lenin raja
1. The document discusses changes to ISO 17025:2017 regarding general requirements for testing and calibration laboratories. It outlines key changes to requirements regarding impartiality, confidentiality, organizational structure, personnel competence, equipment, metrological traceability, externally provided products/services, and method selection/validation.
2. New standards specify that laboratories must be committed to impartiality and minimize risks to impartiality. Personnel must keep information confidential, unless legally required. Laboratories must define their organizational structure and personnel responsibilities.
3. Equipment must be suitable for intended measurements and calibrated when it impacts validity or traceability of results. Laboratories must establish traceability of measurements to SI units through an unbroken chain of calibrations.
Process validation establishes documented evidence that a manufacturing process will consistently produce products meeting specifications. It involves qualifying facilities and equipment, validating critical process parameters, and revalidating when changes occur. Validation includes prospective validation of new processes and retrospective validation of existing stable processes by statistical analysis of historical batch data. Documentation of the validation master plan, protocols, reports, and results provide assurance that processes are properly controlled.
This document discusses quality assurance and quality control procedures for chemical test laboratories to meet ISO/IEC 17025:2017 requirements. It covers establishing quality assurance plans, differentiating quality assurance and quality control, applying quality control practices like blanks, replicates, and laboratory controls. Quality control charts are presented as a tool to monitor analytical accuracy and precision over time.
The document summarizes the key changes and structure of ISO/IEC 17025:2017 compared to the 2005 version. Major changes include an expanded scope to include sampling and a process-based approach. It adopts a new high level structure with common clauses across standards. Key requirements include impartiality, confidentiality, personnel competence, facilities, equipment calibration, metrological traceability, and management of externally provided products and services. The standard aims to ensure laboratories consistently operate at a high level of technical competence and quality.
1) Maintaining quality in an analytical laboratory requires fully integrating quality pursuit into all activities and having staff practice quality at all times.
2) A quality system includes procedures and responsibilities to ensure staff have resources to satisfy clients. It involves quality management, assurance, and control.
3) Key aspects of a quality system include a quality manual, audits to ensure compliance, and management reviews to ensure the system meets needs.
PECB Webinar: Overview of ISO 13485 - Medical DevicesPECB
The webinar covers:
• The key section of ISO 13485
• The benefits of ISO 13485
• In brief how ISO 13485 & ISO 9001 correlate
Presenter:
This webinar was presented by Raza Shah, Chief Editor and Owner of Bitehqeeq.
Link of the recorded session published on YouTube: https://youtu.be/gZlhUlqgo1g
ISPE-CCPIE China Conference 2010 (Stokes-GAMP Legacy Systems - English)David Stokes
This document summarizes two presentations given at the ISPE-CCPIE China Conference 2010 on validating legacy systems. The first presentation discusses validating a global ERP system for a medical device company and a legacy ERP system for a Chinese pharmaceutical company. It provides guidance on assessing legacy systems, conducting a gap analysis, and developing a risk-based validation approach. The second presentation describes a retrospective validation of a global ERP system and a validation conducted for a change in use of a legacy ERP system in China.
Similar to Detailed review of changes and updates.pptx (20)
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfSelcen Ozturkcan
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Travis Hills of MN is Making Clean Water Accessible to All Through High Flux ...Travis Hills MN
By harnessing the power of High Flux Vacuum Membrane Distillation, Travis Hills from MN envisions a future where clean and safe drinking water is accessible to all, regardless of geographical location or economic status.
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...Advanced-Concepts-Team
Presentation in the Science Coffee of the Advanced Concepts Team of the European Space Agency on the 07.06.2024.
Speaker: Diego Blas (IFAE/ICREA)
Title: Gravitational wave detection with orbital motion of Moon and artificial
Abstract:
In this talk I will describe some recent ideas to find gravitational waves from supermassive black holes or of primordial origin by studying their secular effect on the orbital motion of the Moon or satellites that are laser ranged.
The debris of the ‘last major merger’ is dynamically youngSérgio Sacani
The Milky Way’s (MW) inner stellar halo contains an [Fe/H]-rich component with highly eccentric orbits, often referred to as the
‘last major merger.’ Hypotheses for the origin of this component include Gaia-Sausage/Enceladus (GSE), where the progenitor
collided with the MW proto-disc 8–11 Gyr ago, and the Virgo Radial Merger (VRM), where the progenitor collided with the
MW disc within the last 3 Gyr. These two scenarios make different predictions about observable structure in local phase space,
because the morphology of debris depends on how long it has had to phase mix. The recently identified phase-space folds in Gaia
DR3 have positive caustic velocities, making them fundamentally different than the phase-mixed chevrons found in simulations
at late times. Roughly 20 per cent of the stars in the prograde local stellar halo are associated with the observed caustics. Based
on a simple phase-mixing model, the observed number of caustics are consistent with a merger that occurred 1–2 Gyr ago.
We also compare the observed phase-space distribution to FIRE-2 Latte simulations of GSE-like mergers, using a quantitative
measurement of phase mixing (2D causticality). The observed local phase-space distribution best matches the simulated data
1–2 Gyr after collision, and certainly not later than 3 Gyr. This is further evidence that the progenitor of the ‘last major merger’
did not collide with the MW proto-disc at early times, as is thought for the GSE, but instead collided with the MW disc within
the last few Gyr, consistent with the body of work surrounding the VRM.
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...Scintica Instrumentation
Targeting Hsp90 and its pathogen Orthologs with Tethered Inhibitors as a Diagnostic and Therapeutic Strategy for cancer and infectious diseases with Dr. Timothy Haystead.
When I was asked to give a companion lecture in support of ‘The Philosophy of Science’ (https://shorturl.at/4pUXz) I decided not to walk through the detail of the many methodologies in order of use. Instead, I chose to employ a long standing, and ongoing, scientific development as an exemplar. And so, I chose the ever evolving story of Thermodynamics as a scientific investigation at its best.
Conducted over a period of >200 years, Thermodynamics R&D, and application, benefitted from the highest levels of professionalism, collaboration, and technical thoroughness. New layers of application, methodology, and practice were made possible by the progressive advance of technology. In turn, this has seen measurement and modelling accuracy continually improved at a micro and macro level.
Perhaps most importantly, Thermodynamics rapidly became a primary tool in the advance of applied science/engineering/technology, spanning micro-tech, to aerospace and cosmology. I can think of no better a story to illustrate the breadth of scientific methodologies and applications at their best.
Authoring a personal GPT for your research and practice: How we created the Q...Leonel Morgado
Thematic analysis in qualitative research is a time-consuming and systematic task, typically done using teams. Team members must ground their activities on common understandings of the major concepts underlying the thematic analysis, and define criteria for its development. However, conceptual misunderstandings, equivocations, and lack of adherence to criteria are challenges to the quality and speed of this process. Given the distributed and uncertain nature of this process, we wondered if the tasks in thematic analysis could be supported by readily available artificial intelligence chatbots. Our early efforts point to potential benefits: not just saving time in the coding process but better adherence to criteria and grounding, by increasing triangulation between humans and artificial intelligence. This tutorial will provide a description and demonstration of the process we followed, as two academic researchers, to develop a custom ChatGPT to assist with qualitative coding in the thematic data analysis process of immersive learning accounts in a survey of the academic literature: QUAL-E Immersive Learning Thematic Analysis Helper. In the hands-on time, participants will try out QUAL-E and develop their ideas for their own qualitative coding ChatGPT. Participants that have the paid ChatGPT Plus subscription can create a draft of their assistants. The organizers will provide course materials and slide deck that participants will be able to utilize to continue development of their custom GPT. The paid subscription to ChatGPT Plus is not required to participate in this workshop, just for trying out personal GPTs during it.
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Leonel Morgado
Current descriptions of immersive learning cases are often difficult or impossible to compare. This is due to a myriad of different options on what details to include, which aspects are relevant, and on the descriptive approaches employed. Also, these aspects often combine very specific details with more general guidelines or indicate intents and rationales without clarifying their implementation. In this paper we provide a method to describe immersive learning cases that is structured to enable comparisons, yet flexible enough to allow researchers and practitioners to decide which aspects to include. This method leverages a taxonomy that classifies educational aspects at three levels (uses, practices, and strategies) and then utilizes two frameworks, the Immersive Learning Brain and the Immersion Cube, to enable a structured description and interpretation of immersive learning cases. The method is then demonstrated on a published immersive learning case on training for wind turbine maintenance using virtual reality. Applying the method results in a structured artifact, the Immersive Learning Case Sheet, that tags the case with its proximal uses, practices, and strategies, and refines the free text case description to ensure that matching details are included. This contribution is thus a case description method in support of future comparative research of immersive learning cases. We then discuss how the resulting description and interpretation can be leveraged to change immersion learning cases, by enriching them (considering low-effort changes or additions) or innovating (exploring more challenging avenues of transformation). The method holds significant promise to support better-grounded research in immersive learning.
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
2. New structure
1. Scope
2. Normative references
3. Terms and definitions
4. General requirements
5. Structural requirements
6. Resource requirements
7. Process requirements
8. Management requirements
Annex A Metrological traceability
Annex B Management system
3. 1 Scope
This document specifies the general requirements for the
competence, impartiality and consistent operation of laboratories.
This document is applicable to all organizations performing
laboratory activities, regardless of the number of personnel.
Laboratory customers, regulatory authorities, organizations and
schemes using peer-assessment, accreditation bodies, and others
use this document in confirming or recognizing the competence of
laboratories.
4. 3 Terms and definitions
[new or modified]
3.4
intralaboratory comparison
organization, performance and evaluation of measurements or tests
on the same or similar items, within the same laboratory (3.6), in
accordance with predetermined conditions
[New, based on ISO/IEC 17043:2010 definition for “interlaboratory comparison”, which is
included as 3.3 in ISO/IEC 17025:2017]
5. 3 Terms and definitions
[new or modified]
3.5
proficiency testing
evaluation of participant performance against pre-established
criteria by means of interlaboratory comparisons (3.3)
[SOURCE: ISO/IEC 17043:2010, 3.7, modified — Notes to entry have been deleted.]
6. 3 Terms and definitions
[new or modified]
3.6 laboratory
body that performs one or more of the following activities:
− calibration
− testing
− sampling, associated with
subsequent calibration or testing
Note 1 to entry: In the context of this document, “laboratory activities” refer to the three above-
mentioned activities.
7. 3 Terms and definitions
[new or modified]
3.7 decision rule
a rule that describes how measurement uncertainty will be
accounted for when stating conformity with a specified
requirement
9. 4.1 Impartiality
• Language taken from CASCO Procedure document
(consistent with other conformity assessment standards)
• New/changed requirements:
• Identifying and risks to impartiality on an on-going basis
• Addressing risks to impartiality
10. 4.2 Confidentiality
• Language taken from CASCO Procedure document
(consistent with other conformity assessment standards)
• New/changed requirements:
• Stronger emphasis on customer awareness
• More detail regarding specific cases where confidentiality
could be affected
12. 5 Structural requirements
• Removed terms “technical management” and “quality manager”
• Retained same essential functions
• Introduced requirement for laboratory to identify range of
laboratory activities for which it conforms with ISO/IEC 17025
• Restricts claims of conformity to the defined range
• Excludes externally provided laboratory activities on an on-
going basis
13. 5 Structural requirements
• 5.5 c) requires laboratory to “document its procedures to the
extent necessary to ensure the consistent application of its
laboratory activities and the validity of the results.”
• Revised standard consistently uses term “procedure” when
the intent is for laboratory to maintain documentation
• The extend of detail in that documentation is up to the
laboratory, subject to the conditions in 5.5 c)
15. 6.1 General
“The laboratory shall have available the personnel, facilities,
equipment, systems and support services necessary to perform its
laboratory activities.”
• Use of the term “available” indicates an approach in the revision
to focus less on the status or ownership of resources and more
on the relevant requirements for those resources
• Examples:
• 6.2.1 refers to all personnel, internal or external
[vs. 2005 version requiring personnel be employed by or under contract]
• 6.4.1 requires laboratory to have access to equipment
• [vs. 2005 version requiring laboratory be furnished with all items]
16. 6.2 Personnel
• Terminology and requirements have been updated and
reorganized in the revision
• Otherwise, no significant changes to this clause compared to the
2005 version
17. 6.3 Facilities and
environmental conditions
• Terminology and requirements have been updated and
reorganized in the revision
• Otherwise, no significant changes to this clause compared to the
2005 version
18. 6.4 Equipment
6.4.1 The laboratory shall have access to equipment (including,
but not limited to, measuring instruments, software, measurement
standards, reference materials, reference data, reagents,
consumables or auxiliary apparatus) that is required for the correct
performance of laboratory activities and that can influence the
results.
• Description of items considered as equipment is more inclusive
than in 2005 version
• Notes provide more information regarding reference materials
19. 6.4 Equipment
• 6.4.6 identifies two criteria that determine when calibration of
equipment is requirement
– the measurement accuracy or measurement uncertainty
affects the validity of the reported results, or
– calibration of the equipment is required to establish the
metrological traceability of the reported result.
• These criteria apply for all laboratory activities
[2005 version had different requirements for calibration and testing]
• Metrological traceability addressed in a separate clause (6.5)
[2005 version included calibration in the traceability clause]
20. 6.5 Metrological traceability
• Terminology and requirements have been updated in the revision
to reflect current practice in traceability
• Reduced the number of Notes compared to 2005 version
• Additional explanatory information included in Annex A
21. 6.6 Externally provided products
and services
• Combines 4.5 Subcontracting and 4.6 Purchasing services and
supplies from 2005 version
• In all cases, have requirements and controls
• Focuses on communication with customer
Supplies
External services
“Subcontracting”
• Select
• Control
• Verify
Competent
Supplier
23. 7.1 Review of requests, tenders
and contracts
New/updated requirements
• 7.1.3 requires statements of conformity and associated decision
rules be addressed during contract review
• 7.1.4 states that deviations requested by the customer shall not
impact the integrity of the laboratory or the validity of the results
24. 7.2 Selection, verification and
validation of methods
• Terminology and organization of clause updated from 2005
version
• Note after 7.2.1.1 clarifies that “method” as used in this document
can be considered synonymous with the term “measurement
procedure” as defined in ISO/IEC Guide 99.
25. 7.3 Sampling
• Definition of laboratory (3.6) clarifies that the sampling activity is
associated with subsequent testing or calibration
• Otherwise, no significant changes to this clause compared to the
2005 version
26. 7.4 Handling of test or calibration
items
• 7.4.3 includes a new requirement:
“When the customer requires the item to be tested or calibrated
acknowledging a deviation from specified conditions, the
laboratory shall include a disclaimer in the report indicating which
results may be affected by the deviation.”
• Otherwise, no significant changes to this clause compared to the
2005 version
27. 7.5 Technical records
• Technical records placed in this clause as process requirements
• Other types of records (e.g., management system records)
addressed in Clause 8
• Otherwise, no significant changes to this clause compared to the
2005 version
28. 7.6 Evaluation of measurement
uncertainty
• 7.6.1 requires all laboratories to identify contributions to
measurement uncertainty
• 7.6.2 requires evaluation of measurement uncertainty for all
calibrations, including those a laboratory performs on its own
equipment (i.e. “in-house” calibrations)
• 7.6.3 includes essentially the same requirements for evaluation of
uncertainty for testing as the 2005 version
• Note 2 applies to all laboratories, and clarifies that a laboratory is
not required to calculate a unique uncertainty every time a test or
calibration is performed provided the stated conditions are met
29. 7.7 Ensuring the validity of results
• Clause separates requirements for monitoring done within the
laboratory (7.7.1) and those involving comparison with other
laboratories (7.7.2)
• Data from internal activities (7.7.1) required to be recorded such
that trends can be detected and, where practicable, statistical
techniques applied
• Both required to be planned and reviewed, analyzed, used to
control and (if applicable) improve laboratory activities
• Action required when results of analysis of data found to be
outside pre-defined criteria
30. 7.8 Reporting of results
• Language reflects current approaches to reporting
• New/updated requirements
• 7.8.2.2 addresses data provided by a customer, including a
disclaimer when those data can affect validity of results
• 7.8.5 reporting sampling
• 7.8.6 reporting statements of conformity
31. 7.9 Complaints
• Language taken from CASCO Procedure document
(consistent with other conformity assessment standards)
• New/updated requirements
• 7.9.2 requires a description of the complaints handling process
be available to any interested party upon request
• 7.9.6 requires the outcomes to be communicated to the
complainant be made by, or reviewed and approved by,
individual(s) not involved in the original laboratory activities in
question
33. 7.11 Control of data and
information management
• Extends and updates 5.4.7 in the 2005 version to address current
laboratory practice
• 7.11.2 Note 1 clarifies that use of the term “laboratory information
management system(s)” in this document includes both
computerized and non-computerized systems
• 7.11.4 requires laboratory to ensure that off-site or external
providers of information management comply with applicable
requirements of ISO/IEC 17025
35. 8.1 Options
• The revision now provides two distinct options (A or B) for
establishing a management system
• Option A: As a minimum the management system of the
laboratory shall address the requirements in clauses 8.2 to 8.9
• Option B: Establish and maintain a management system in
accordance with the requirements of ISO 9001
• Both options require that the management system is capable of
supporting and demonstrating the consistent achievement of the
requirements of ISO/IEC 17025 clauses 4 to 7 and assuring the
quality of the laboratory results.
• Laboratories need only conform to one of the options (not both)
36. New
8.1.2 Option A
As a minimum the management system of the
laboratory shall address the following:
– management system documentation (see 8.2)
– control of management system documents (see 8.3)
– control of records (see 8.4)
– actions to address risks and opportunities (see 8.5)
– improvement (see 8.6)
– corrective action (see 8.7)
– internal audits (see 8.8)
– management review (see 8.9)
8.1 Options
Aligned with
ISO 9001:2015
Similar to 2005
version
37. 8.5 Actions to address risks and
opportunities (Option A)
• Revision incorporates “risked-based thinking”
• Introduction and Note after 8.5.2 include two important points:
• There is no requirement for formal methods for risk
management or a documented risk management process
• The laboratory is responsible for deciding which risks and
opportunities need to be addressed
38. Thank you
For questions contact: casco@iso.org
For additional resources visit the ISO page dedicated to ISO/IEC 17025.